OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 11 results.
Search:

SKU Category Vector Description Price Delivery
TA314705-100 Antibody 100 ul Rabbit polyclonal anti-MAPK3 antibody $325 In Stock
/ CRISPR MAPKAPK3 - human gene knockout kit via CRISPR $1200 4 Weeks
SC332053 Human cDNA pCMV6 series MAPKAPK3 (untagged) - Homo sapiens mitogen-activated protein kinase-activated protein kinase 3 (MAPKAPK3), transcript variant 2 NM_001243925.1 $340 12-13 weeks
RC233933 Human ORF PS100001 MAPKAPK3 (Myc-DDK tagged) - Homo sapiens mitogen-activated protein kinase-activated protein kinase 3 (MAPKAPK3), transcript variant 2 $380 12-13 weeks
RG233933 Human ORF PS100010 MAPKAPK3 (GFP-tagged) - Homo sapiens mitogen-activated protein kinase-activated protein kinase 3 (MAPKAPK3), transcript variant 2 $420 12-13 weeks
TF320575 Human shRNA pRFP-C-RS MAPKAPK3 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector $498 In Stock
TG320575 Human shRNA pGFP-V-RS MAPKAPK3 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector $650 2 Weeks
TL320575 Human shRNA pGFP-C-shLenti MAPKAPK3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector $750 2 Weeks
TL320575V Human shRNA pGFP-C-shLenti MAPKAPK3 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^6 TU/ml. $1200 5 weeks
TR320575 Human shRNA pRS MAPKAPK3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector $650 2 Weeks
/ Human siRNA MAPKAPK3 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each $300 In Stock
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title